Each year, nearly 400,000 children under five years of age die globally from pneumococcal disease, mostly in Africa and Asia. WHO prequalification opens the door for this new vaccine, PNEUMOSIL®, to bolster the prevention toolkit and fulfill its purpose—to save more lives by enabling access that countries in these regions can afford and sustain long term.
Pneumonia is the leading infectious cause of death globally, in children and adults. It kills more children each year than HIV, tuberculosis, and malaria combined. Despite pneumonia’s global burden, the medical community is still unable to accurately and efficiently diagnose it. It remains perplexing why in this day and age — having mapped the human genome, contemplating colonizing Mars, and anticipating the development of a SARS-CoV-2 vaccine — we cannot come up with better ways to diagnose pneumonia than counting breaths in children.
Pneumonia is the No. 1 hospital-acquired infection in America and hospitals aren’t doing enough to fight it. The best weapon: a toothbrush.
It is critical to provide children with basic human needs like adequate nourishment, access to clean water and air, and equitable access to vaccines and basic healthcare.
The costs associated with improving children’s living conditions must be evaluated against the high costs associated with the clinical management of childhood pneumonia. The residual burden of pneumonia can be reduced by prioritising child health through simple interventions. These include improving living conditions and accessibility to affordable medication, vaccines and care.
Well, you ain't imagining things. Legionnaires' Disease, which is a more severe form of legionellosis, has been like raw steak on a very slow flame. It is still very rare but seems to be becoming less rare over time.
In 2013, WHO and UNICEF released the Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea, which set a target of less than three child pneumonia deaths per 1,000 live births in every country by 2025.
Why is it important to continue research on pneumonia in people of all generations? The most obvious reason is because everyone matters. Worldwide respiratory tract infections are the leading cause of infectious death in children and the elderly; to focus pneumonia research on just one age group would be to ignore what is a major problem for the other.
Pneumonia is a clever killer, responsible each year for the deaths of more than a million children under five years old, most of them in the developing world. If you want to know how serious this respiratory disease is, consider one fact: pneumonia kills more young children worldwide than any other disease.
Prevnar, the vaccine against the pneumococcus bacterium, is one of the greatest pharmaceutical innovations of the past two decades. In children who are vaccinated, it eliminated most of the pneumonia and meningitis that bacteria causes. It proved so effective, in fact, that fewer pneumococcal infections occur in people over 65 who have never gotten the vaccine, because the germs are no longer circulating. It has, quite simply, changed the world for the better.
However, a breath of fresh air is now revitalising efforts to combat pneumonia in the form of a new international coalition bringing together more than 30 international institutions, including the ”la Caixa” Banking Foundation—one of the most important and coherent philanthropic actors in the field of pneumonia—and the Barcelona Institute for Global Health (http://www.isglobal.org/en).
On Monday, my editors asked me to write about Hillary Clinton’s pneumonia, partially because I am, after all, a health writer (though my beat is global, not presidential), and partially because I too have pneumonia. I’m about two weeks ahead of her.
Bacteria are the top cause of pneumonia, but viruses cause about a fifth of the pneumonia cases. Fungi can also cause pneumonia, but this is very rare and typically in those with a very weak immune system (like in HIV or chemotherapy patients).
I spent the last two days in the hospital with pneumonia. And let me tell you, it’s far from fun.
We have “eradication” targets for polio, “elimination” targets for malaria, and “generation-free” targets for HIV/AIDS, but for a disease that kills more children under five than all three combined, we have…well…very little.
The last century has been witness to vast medical advancements that have saved the lives of hundreds of millions of people around the world. Yet recent figures show that in 2015 alone, nearly a million children died of pneumonia. It is both astounding and saddening that despite the availability of simple provisions that can both prevent and cure the disease, marginalised children are being denied access to the right drugs to save their lives.
I am not a physician nor do I play one on TV. But I have had “Walking Pneumonia” four times in my life – in 1982, 1983, 1984 and 1986. (Since that time a powerful pneumonia shot has been developed, generally good for ten years or so, and I have been blessed). But my point is that I know this ailment. It is not fatal nor does it have to be life threatening but it requires care. Walking pneumonia is very sinister and it creeps up on you with sore throats, coughing, then too much coughing.
It makes them more vulnerable to other problems. Because of its rapid onset and ability to spread to other parts of the body (as opposed to a stroke or heart attack), pneumonia can be lethal. Even a milder case deals a severe blow to your immune system, which can turn an underlying condition like heart disease into a life-threatening malady.
We discuss a fair number of grim topics hereabouts, so when I hear about good news, I figure I should grab it.
So let me pass along two encouraging developments on the pneumonia front. First, the Centers for Disease Control and Prevention has just issued new vaccination recommendations for older adults that should bolster their protection against this dangerous lung infection.
Second, a large-scale study has found that when older Americans do land in hospitals with pneumonia, those hospitals are doing a measurably better job of treating them.
Now, a new paper from Stanford University shows just how fast a new dataset could be used to train artificial intelligence algorithms to the point of near-human accuracy. Using 100,000 x-ray images released by the National Institutes of Health on Sept. 27, the research published Nov. 14 (without peer review) on the website ArXiv claims its AI can detect pneumonia from x-rays with similar accuracy to four trained radiologists.
Last winter, my worst pneumonia case involved a school-aged girl whose mother is a very close friend of mine. First off, I would like to mention, she rarely calls me with medical questions; sometimes, I wish she would call me a little more often, especially that particular Sunday night.
Pneumonia can be divided into two very general types, community acquired and hospital acquired. The first is what will be more prevalent during a disaster—especially if many people are sheltering together.
Mark Alderson won’t rest easy until he solves one of the biggest problems in global health: a vaccine against pneumonia.
Pneumonia is a historically feared phenomenon. Around 1200, the medieval philosopher Maimonides described the basic symptoms of pneumonia as “acute fever, sticking (pleuritic) pain in the side, short rapid breaths, serrated pulse and cough.” Even after Louis Pasteur’s Germ Theory began to inform the treatment of bacterial diseases such as pneumonia in 1861, the illness continued in its infamy as treacherous. In 1918, William Osler proclaimed that pneumonia is “the captain of the men of death.”
There are two types of pneumonia we talk about in medicine. The first is typical pneumonia or community-acquired pneumonia (CAP). This type generally affects young children and older adults and can make you very sick over a short period of time. The other type is atypical pneumonia, more commonly known as “walking pneumonia.” It gets this moniker because the symptoms are generally less severe than typical pneumonia, allowing those infected to continue “walking” around. Infection may seem more like a bad cold that never really seems to go away.
Pneumonia kills more children than any other infectious disease. Globally, close to 1 million under five children die from this preventable disease every year – the equivalent of more than 2,500 dying every day. That’s more than the death tolls of diarrhoea, malaria and HIV combined for this age group. Yet you will hear of no global campaign or cause to end pneumonia.
Creativity, collaboration, and a multidimensional strategy go a long way in the fight against the world’s top childhood killer.
World’s first public-private partnership to support national governments to end preventable child pneumonia deaths by 2030.
Pneumococcal pneumonia is more common than you think. And, if you're over 50, you may be at increased risk for getting it.
An international, peer reviewed open access journal that publishes original research articles, case studies, reviews, commentaries, correspondence and highlights, news and activities on all aspects related to pneumonia.
Aiming to achieve unprecedented levels of collaboration to improve the quality, availability, and affordability of pneumonia prevention, diagnostic and treatment innovations for children.
Stopping pneumonia isn’t about luck. It’s about action.
Stop Pneumonia is an initiative that provides a voice for communities who suffer from the devastating consequences of the disease and who lack access to lifesaving interventions.
The reported incidence of viral pneumonia has increased during the past decade. In part, this apparent increase simply reflects improved diagnostic techniques, but an actual increase appears to have also occurred. Depending on the virulence of the organism, as well as the age and comorbidities of the patient, viral pneumonia can vary from a mild, self-limited illness to a life-threatening disease.
Pneumonia is a common lung infection caused by germs, such as bacteria, viruses, and fungi. It can be a complication of the flu, but other viruses, bacteria and even fungi can cause pneumonia.
The most common cause of pneumonia is a type of bacterium called Streptococcus pneumoniae. Other bacteria can cause also the condition, including Haemophilus influenzae (Hib), Staphylococcus aureus and Mycoplasma pneumoniae. For more information about Mycoplasma pneumoniae infections, see our FAQ on atypical pneumonia. Other, less common, causes of pneumonia include: viruses, including the flu virus and, especially in children, respiratory syncytial virus (RSV)...
Walking pneumonia is a mild case of pneumonia. It is often caused by a virus or the Mycoplasma pneumoniae bacteria. When you have walking pneumonia, your symptoms may not be as severe or last as long as someone who has a more serious case of pneumonia. You probably won’t need bed rest or to stay in the hospital when you have walking pneumonia.
Terms such as bronchopneumonia, lobar pneumonia and double pneumonia are sometimes used, but refer to the same condition with the same causes and treatment.
The World Health Organization estimates that more than 160 million children around the world develop pneumonia each year, 20 million of whom are hospitalized and 2 million of whom die. Worldwide, pneumonia is the leading cause of death for children under the age of five. Sub-Saharan Africa is disproportionately affected, accounting for more than half of such cases.
Pneumonia is a common illness, occurs in all age groups, and is a leading cause of death among the elderly and people who are chronically ill. Pneumonia can result from a variety of causes, including infection with bacteria, viruses, fungi, or parasites.
Pneumonia may also occur from chemical or physical injury to the lungs, or indirectly due to another medical illness, such as lung cancer or alcohol abuse.
Pneumonia is still a single leading cause of child death, killing 1 child every 35 seconds.
Pneumonia is an infection of the lungs. It is a serious illness that can affect people of any age, but it is most dangerous in very young children, people older than 65, and in those with underlying medical problems such as heart disease, diabetes, and chronic lung disease. It is most common during the winter months and occurs more often in smokers and men.